Inherited homozygous resistance to activated protein C. 1995

P Villa, and J Aznar, and J Jorquera, and Y Mira, and A Vayá, and M A Fernández

UI MeSH Term Description Entries
D008297 Male Males
D011486 Protein C A vitamin-K dependent zymogen present in the blood, which, upon activation by thrombin and thrombomodulin exerts anticoagulant properties by inactivating factors Va and VIIIa at the rate-limiting steps of thrombin formation.
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D005165 Factor V Heat- and storage-labile plasma glycoprotein which accelerates the conversion of prothrombin to thrombin in blood coagulation. Factor V accomplishes this by forming a complex with factor Xa, phospholipid, and calcium (prothrombinase complex). Deficiency of factor V leads to Owren's disease. Coagulation Factor V,Proaccelerin,AC Globulin,Blood Coagulation Factor V,Factor 5,Factor Five,Factor Pi,Factor V, Coagulation
D005166 Factor V Deficiency A deficiency of blood coagulation factor V (known as proaccelerin or accelerator globulin or labile factor) leading to a rare hemorrhagic tendency known as Owren's disease or parahemophilia. It varies greatly in severity. Factor V deficiency is an autosomal recessive trait. (Dorland, 27th ed) Owren Disease,Parahemophilia,Deficiency, Factor 5,Deficiency, Factor Five,Deficiency, Factor V,Factor 5 Deficiency,Factor Five Deficiency,Labile Factor Deficiency,Owren Parahemophilia,Owren's Disease,Deficiencies, Factor 5,Deficiencies, Factor Five,Deficiencies, Factor V,Deficiencies, Labile Factor,Deficiency, Labile Factor,Disease, Owren,Disease, Owren's,Factor 5 Deficiencies,Factor Five Deficiencies,Factor V Deficiencies,Labile Factor Deficiencies,Owrens Disease,Parahemophilia, Owren,Parahemophilias
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D017354 Point Mutation A mutation caused by the substitution of one nucleotide for another. This results in the DNA molecule having a change in a single base pair. Mutation, Point,Mutations, Point,Point Mutations

Related Publications

P Villa, and J Aznar, and J Jorquera, and Y Mira, and A Vayá, and M A Fernández
September 1995, American journal of clinical pathology,
P Villa, and J Aznar, and J Jorquera, and Y Mira, and A Vayá, and M A Fernández
March 1995, American journal of clinical pathology,
P Villa, and J Aznar, and J Jorquera, and Y Mira, and A Vayá, and M A Fernández
October 1994, Lancet (London, England),
P Villa, and J Aznar, and J Jorquera, and Y Mira, and A Vayá, and M A Fernández
March 2005, Archives of dermatology,
P Villa, and J Aznar, and J Jorquera, and Y Mira, and A Vayá, and M A Fernández
March 1997, British journal of haematology,
P Villa, and J Aznar, and J Jorquera, and Y Mira, and A Vayá, and M A Fernández
January 1997, Clinical laboratory science : journal of the American Society for Medical Technology,
P Villa, and J Aznar, and J Jorquera, and Y Mira, and A Vayá, and M A Fernández
January 1997, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association,
P Villa, and J Aznar, and J Jorquera, and Y Mira, and A Vayá, and M A Fernández
March 1996, Annals of vascular surgery,
P Villa, and J Aznar, and J Jorquera, and Y Mira, and A Vayá, and M A Fernández
October 1996, Haemostasis,
P Villa, and J Aznar, and J Jorquera, and Y Mira, and A Vayá, and M A Fernández
May 2000, Clinical nephrology,
Copied contents to your clipboard!